A bayesian dose-finding design for drug combination trials with delayed toxicities

Bayesian Analysis

Volumn 8, Issue 3, 2013, Pages 703-722

  Liu, Suyu ^a   Ning, Jing ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adaptive design; Combining drugs; Late onset toxicity; Maximum tolerated dose; Missing data; Phase I trial

Indexed keywords

EID: 84884685127     PISSN: 19360975     EISSN: 19316690     Source Type: Journal    
DOI: 10.1214/13-BA839     Document Type: Article

References (22)

1. Braun, T. M. and Wang, S. (2010). "A hierarchical Bayesian design for phase I trials of novel combinations of cancer therapeutic agents." Biometrics, 66: 805-812.
2. Cheung, K. Y. and Chappell, R. (2000). "Sequential designs for phase I clinical trials with late-onset toxicities." Biometrics, 56: 1177-1182.
3. Coia, L. R., Myerson, R., and Tepper, J. E. (1995). "Late effects of radiation therapy on the gastrointestinal tract." International Journal of Radiation Oncology, Biology, Physics, 31: 1213-1236.
4. Conaway, M. R., Dunbar, S., and Peddada, S. D. (2004). "Designs for single- or multipleagent phase I trials." Biometrics, 60: 661-669.
5. Cooper, J. S., Fu, K., Marks, J., and Silverman, S. (1995). "Late effects of radiation therapy in the head and neck region." International Journal of Radiation Oncology, Biology, Physics, 31: 1141-1164.
6. Finney, D. (1971). Probit Analysis. Cambridge: Cambridge University Press. 704
7. Govindarajulu, Z. (2001). Statistical Techniques in Bioassay. Basel: Karger., 2 edition. 705
8. Greco, W. R., Bravo, G., and Parsons, J. C. (1995). "The search for synergy: a critical review from a response surface perspective." Pharmacological Reviews, 47: 331-385.
9. Houede, N., Thall, P. F., Nguyen, H., Paoletti, X., and Kramar, A. (2010). "Utilitybased optimization of combination therapy using ordinal toxicity and efficacy in phase I/II trials." Biometrics, 66: 532-540.
10. Loewe, S. and Muischnek, H. (1926). "Effect of combinations: mathematical basis of the problem." Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 114: 313-326.
11. Mauguen, A., Le Deley, M. C., and Zohar, S. (2011). "Dose-finding approach for dose escalation with overdose control considering incomplete observations." Statistics in Medicine, 30: 1584-1594.
12. Muler, J. H., McGinn, C. J., Normolle, D., Lawrence, T., Brown, D., Hejna, G., and Zalupski, M. M. (2004). "Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer." Journal of Clinical Oncology, 22: 238-243.
13. Paoletti, X. and Kramar, A. (2009). "A comparison of model choices for the continual reassessment method in phase I cancer trials." Statistics in Medicine, 28: 3012-3028.
14. Postel-Vinay, S., Gomez-Roca, C., Molife, L. R., Anghan, B., Levy, A., Judson, I., Bono, J. D., Soria, J., Kaye, S., and Paoletti, X. (2011). "Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities?" Journal of Clinical Oncology, 29: 1728-1735.
15. Tanner, M. A. and Wong, W. H. (1987). "The calculation of posterior distributions by data augmentation (with discussion)." Journal of the American Statistical Associa- tion, 82: 528-550.
16. Thall, P. F., Millikan, R. E., Müller, P., and Lee, S.-J. (2003). "Dose-finding with two agents in phase I oncology trials." Biometrics, 59: 487-496.
17. Wages, N. A., Conaway, M. R., and O'Quigley, J. (2011). "Continual Reassessment Method for Partial Ordering." Biometrics, 67: 1555-1563.
18. Wang, K. and Ivanova, A. (2005). "Two-Dimensional Dose Finding in Discrete Dose Space." Biometrics, 61: 217-222.
19. Yin, G. and Yuan, Y. (2009a). "Bayesian dose finding in oncology for drug combinations by copula regression." Journal of the Royal Statistical Society: Series C (Applied Statistics), 58: 211-224.
20. Yin, G. and Yuan, Y. (2009b). "A latent contingency table approach to dose finding for combinations of two agents." Biometrics, 27: 866-875.
21. Yuan, Y. and Yin, G. (2008). "Sequential continual reassessment method for twodimensional dose finding." Statistics in Medicine, 27: 5664-5678.
22. Yuan, Y. and Yin, G. (2011). "Robust EM Continual Reassessment Method in Oncology Dose Finding." Journal of the American Statistical Association, 106: 818-831.